口服营养补充剂干预改善血液透析患者蛋白质能量消耗的临床研究效果观察

Clinical observation on the efficacy of oral nutritional supplement intervention in ameliorating protein-energy wasting in hemodialysis patients

ES评分 0

DOI 10.12208/j.ijcr.20260210
刊名
International Journal of Clinical Research
年,卷(期) 2026, 10(4)
作者
作者单位

深圳市膳能士科技有限公司 广东深圳;

摘要
本研究旨在观察口服营养补充剂干预对改善血液透析患者蛋白质能量消耗的临床效果。选取一定数量的血液透析患者,随机分为干预组和对照组。干预组采用某口服营养补充剂的具有0磷、0钾、0乳糖、富含膳食纤维及多种维生素矿物质特点的口服营养补充剂进行干预,对照组采用常规护理。观察周期内对比两组患者的营养指标变化、蛋白质能量消耗情况以及相关并发症的发生情况。结果显示,干预组患者在补充营养蛋白质、控制磷钾摄入方面表现更优,蛋白质能量消耗得到有效改善,并发症发生率降低。结论:表明沧泽制药的口服营养液补充剂在改善血液透析患者蛋白质能量消耗方面具有良好的临床应用价值。
Abstract
This study aimed to observe the clinical efficacy of oral nutritional supplement intervention in improving protein-energy wasting among hemodialysis patients. A certain number of hemodialysis patients were enrolled and randomly divided into intervention group and control group. The intervention group was given oral nutritional supplements characterized by zero phosphorus, zero potassium, zero lactose, rich in dietary fiber as well as various vitamins and minerals, while the control group received routine nursing care. During the observation period, changes in nutritional indicators, protein-energy wasting status and incidence of related complications were compared between the two groups. The results showed that patients in the intervention group achieved better effects in nutritional protein supplementation and phosphorus and potassium intake control, with effectively relieved protein-energy wasting and reduced incidence of complications. Conclusion: The oral nutritional liquid supplement produced by Cangze Pharmaceutical possesses favorable clinical application value in improving protein-energy wasting in hemodialysis patients.
关键词
血液透析;蛋白质能量消耗;口服营养补充剂;临床效果
KeyWord
Hemodialysis; Protein-energy wasting; Oral nutritional supplements; Clinical efficacy
基金项目
页码 156-158
  • 参考文献
  • 相关文献
  • 引用本文

甘运基. 口服营养补充剂干预改善血液透析患者蛋白质能量消耗的临床研究效果观察 [J]. 国际临床研究杂志. 2026; 10; (4). 156 - 158.

  • 文献评论

相关学者

相关机构